How an integrated development platform can provide end-to-end visibility across pre-formulations and formulations development.
How to overcome the challenges the shift from internal to external, or virtual, R&D teams poses.
A solution designed to provide a working environment that is easy to use across multiple disciplines to meet the full range of scientific needs.
A lack of consistency in the capture, management and analysis of data is a barrier to both collaboration and understanding, and hampers the development of novel products and processes.
How an integrated pharmaceutical development platform can meet the needs of both analytical development and QC teams through shorter turnaround times, fewer repeats and higher quality.
Sterile suspensions are particularly difficult to manufacture. This technical article covers factors for success, including particle size, vehicle formulation, and considerations for high-shear mixing.
When developing a parenteral product, pharmaceutical scientists are faced with a variety of choices – choices that can be conflicting or present differing advantages. With careful planning and strategic foresight, these advantages can be leveraged to great effect during the development program. Read the whitepaper to learn more.
Biopharmaceutical executives must consider how outsourcing fits into their development and production strategy, as well as how to select the best CDMO partner for their business. Here’s a step-by-step guide to help make that decision.
Solving the bottleneck in gene therapy of manufacturing of viral material at sufficient cost and scale.
Several characteristics are important to the performance of BPCs, including biological compatibility, physical and mechanical properties, and extractables and leachables (E&L).
|
|
|
|
|
|
|
|
|